The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood eosinophils as prognostic biomarkers for advanced urothelial carcinoma in patients treated with avelumab: First results of the MALVA study (Meet-URO 25).
 
Elisabetta Gambale
No Relationships to Disclose
 
Marco Maruzzo
No Relationships to Disclose
 
Carlo Messina
Consulting or Advisory Role - MSD
Speakers' Bureau - Astellas Oncology; Merck; MSD
Travel, Accommodations, Expenses - Ipsen; MSD; Pfizer
 
Irene De Gennaro Aquino
No Relationships to Disclose
 
Ismaela Anna Vascotto
No Relationships to Disclose
 
Virginia Rossi
No Relationships to Disclose
 
Davide Bimbatti
No Relationships to Disclose
 
Nicolò Cavasin
No Relationships to Disclose
 
Marco Messina
Consulting or Advisory Role - Sanofi
 
Alessia Mennitto
No Relationships to Disclose
 
Sara Elena Rebuzzi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Lilly O.; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Chiara Mercinelli
No Relationships to Disclose
 
Martina Fanelli
Travel, Accommodations, Expenses - Astellas Oncology; Janssen Oncology
 
Mariella Sorarù
No Relationships to Disclose
 
Federico Scolari
No Relationships to Disclose
 
Marinella Micol Mela
No Relationships to Disclose
 
Laura Doni
No Relationships to Disclose
 
Serena Pillozzi
No Relationships to Disclose
 
Lorenzo Antonuzzo
No Relationships to Disclose